Lung adenocarcinoma NCI-H1299 and A549 cells in PYCR1-silenced/vector control/blank control groups were treated with different concentrations of cisplatin, and the rate of inhibition on the proliferation was detected using the CCK8 assay. This evidence concerns the gene PYCR1 and lung adenocarcinoma.